These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 9581865)

  • 1. High affinity MAR-DNA binding is a common property of murine and human mutant p53.
    Will K; Warnecke G; Albrechtsen N; Boulikas T; Deppert W
    J Cell Biochem; 1998 Jun; 69(3):260-70. PubMed ID: 9581865
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Specific interaction of mutant p53 with regions of matrix attachment region DNA elements (MARs) with a high potential for base-unpairing.
    Will K; Warnecke G; Wiesmüller L; Deppert W
    Proc Natl Acad Sci U S A; 1998 Nov; 95(23):13681-6. PubMed ID: 9811860
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Specific and complex interactions of murine p53 with DNA.
    Weissker SN; Müller BF; Homfeld A; Deppert W
    Oncogene; 1992 Oct; 7(10):1921-32. PubMed ID: 1408133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Specific binding of MAR/SAR DNA-elements by mutant p53.
    Müller BF; Paulsen D; Deppert W
    Oncogene; 1996 May; 12(9):1941-52. PubMed ID: 8649855
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human p53 phosphorylation mimic, S392E, increases nonspecific DNA affinity and thermal stability.
    Nichols NM; Matthews KS
    Biochemistry; 2002 Jan; 41(1):170-8. PubMed ID: 11772014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation between the conformational phenotype of p53 and its subcellular location.
    Zerrahn J; Deppert W; Weidemann D; Patschinsky T; Richards F; Milner J
    Oncogene; 1992 Jul; 7(7):1371-81. PubMed ID: 1620550
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Partially transformed T3T3 cells express high levels of mutant p53 in the 'wild-type' immunoreactive form with defective oligomerization.
    Milner J; Chan YS; Medcalf EA; Wang Y; Eckhart W
    Oncogene; 1993 Jul; 8(7):2001-8. PubMed ID: 8510941
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Binding of MAR-DNA elements by mutant p53: possible implications for its oncogenic functions.
    Deppert W
    J Cell Biochem; 1996 Aug; 62(2):172-80. PubMed ID: 8844397
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Site-specific binding of wild-type p53 to cellular DNA is inhibited by SV40 T antigen and mutant p53.
    Bargonetti J; Reynisdóttir I; Friedman PN; Prives C
    Genes Dev; 1992 Oct; 6(10):1886-98. PubMed ID: 1398068
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A proteolytic fragment from the central region of p53 has marked sequence-specific DNA-binding activity when generated from wild-type but not from oncogenic mutant p53 protein.
    Bargonetti J; Manfredi JJ; Chen X; Marshak DR; Prives C
    Genes Dev; 1993 Dec; 7(12B):2565-74. PubMed ID: 8276239
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Specific p53-DNA complexes contain an mdm2-related protein.
    Hall AR; Milner J
    Oncogene; 1997 Mar; 14(11):1371-6. PubMed ID: 9178897
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutant p53: "gain of function" through perturbation of nuclear structure and function?
    Deppert W; Göhler T; Koga H; Kim E
    J Cell Biochem Suppl; 2000; Suppl 35():115-22. PubMed ID: 11389540
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transactivational and DNA binding abilities of endogenous p53 in p53 mutant cell lines.
    Park DJ; Nakamura H; Chumakov AM; Said JW; Miller CW; Chen DL; Koeffler HP
    Oncogene; 1994 Jul; 9(7):1899-906. PubMed ID: 8208536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of genomic DNA sequences bound by mutant p53 protein (Gly245-->Ser) in vivo.
    Koga H; Deppert W
    Oncogene; 2000 Aug; 19(36):4178-83. PubMed ID: 10962580
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Probing the functional impact of sequence variation on p53-DNA interactions using a novel microsphere assay for protein-DNA binding with human cell extracts.
    Noureddine MA; Menendez D; Campbell MR; Bandele OJ; Horvath MM; Wang X; Pittman GS; Chorley BN; Resnick MA; Bell DA
    PLoS Genet; 2009 May; 5(5):e1000462. PubMed ID: 19424414
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNA binding properties of murine p53.
    Steinmeyer K; Deppert W
    Oncogene; 1988 Nov; 3(5):501-7. PubMed ID: 2978867
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutations at position 277 modify the DNA-binding specificity of human p53 in vitro.
    Chène P
    Biochem Biophys Res Commun; 1999 Sep; 263(1):1-5. PubMed ID: 10486243
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutant p53 proteins bind DNA in a DNA structure-selective mode.
    Göhler T; Jäger S; Warnecke G; Yasuda H; Kim E; Deppert W
    Nucleic Acids Res; 2005; 33(3):1087-100. PubMed ID: 15722483
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutant p53 forms a complex with Sp1 on HIV-LTR DNA.
    Chicas A; Molina P; Bargonetti J
    Biochem Biophys Res Commun; 2000 Dec; 279(2):383-90. PubMed ID: 11118296
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The interaction between p53 and DNA topoisomerase I is regulated differently in cells with wild-type and mutant p53.
    Gobert C; Skladanowski A; Larsen AK
    Proc Natl Acad Sci U S A; 1999 Aug; 96(18):10355-60. PubMed ID: 10468612
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.